{"gene":"NKX2-2","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1999,"finding":"Nkx2.2 is required downstream of graded Sonic hedgehog signaling to specify ventral neuronal identity in the neural tube; in Nkx2.2 mutant mice, progenitor cells that normally form V3 interneurons instead generate motor neurons, while Pax6 expression remains unchanged, placing Nkx2.2 as a primary interpreter of graded Shh signals rather than an indirect effector of Pax6.","method":"Loss-of-function mouse genetics (Nkx2.2 null mutants), immunohistochemistry, epistasis analysis with Pax6 mutants","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, epistasis with Pax6 mutants, replicated in multiple analyses","pmids":["10217145"],"is_preprint":false},{"year":1998,"finding":"Nkx2.2 is required for the final differentiation of pancreatic beta cells; mice lacking Nkx2.2 completely lack insulin-producing beta cells and have reduced alpha and PP cells, with remaining islet cells expressing some but not all beta cell markers (e.g., IAPP and Pdx1 present, but Glut2 and Nkx6.1 absent), indicating beta cells are arrested in an incompletely differentiated state.","method":"Null mouse genetics, immunohistochemistry, marker expression analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple orthogonal marker analyses, widely replicated","pmids":["9584121"],"is_preprint":false},{"year":2001,"finding":"Co-expression of Nkx2.2 and Olig2 in the spinal cord promotes ectopic and precocious oligodendrocyte differentiation; both proteins function as transcriptional repressors in this assay, and forced Neurogenin1 expression blocks this cooperative effect.","method":"Ectopic expression in chick spinal cord (electroporation), reporter assays, epistasis with Neurogenin1","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo gain-of-function with defined phenotype, functional epistasis, replicated across multiple studies","pmids":["11567617"],"is_preprint":false},{"year":2000,"finding":"Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell differentiation; Nkx6.1/Nkx2.2 double mutant islet development is identical to Nkx2.2 single mutant development (beta-cell precursors survive but fail to differentiate), establishing Nkx6.1 downstream of Nkx2.2.","method":"Double-mutant mouse genetics, epistasis analysis, immunohistochemistry","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double-mutant rescue logic, clean KO phenotype","pmids":["11076772"],"is_preprint":false},{"year":2001,"finding":"Nkx2.2 regulates the differentiation and maturation (but not initial specification) of oligodendrocyte progenitors in the rodent CNS; Nkx2.2-null mutants show dramatically retarded MBP+ and PLP-DM20+ oligodendrocyte differentiation along the entire rostrocaudal axis, while astrocytic differentiation is unaffected. Additionally, absence of Nkx2.2 causes ventral expansion of Olig1/Olig2 expression.","method":"Loss-of-function mouse genetics (Nkx2.2 null), immunohistochemistry, overexpression in fibroblasts (PLP promoter reporter)","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, gain-of-function corroboration, multiple markers","pmids":["11526078"],"is_preprint":false},{"year":2006,"finding":"NKX2.2 is a transcriptional target of the EWS/FLI fusion protein in Ewing's sarcoma and is necessary for the oncogenic transformation phenotype; knockdown of NKX2.2 by RNAi in Ewing's sarcoma cells abrogates tumorigenic properties.","method":"Retroviral RNAi knockdown, reexpression rescue, microarray expression profiling","journal":"Cancer Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function with defined oncogenic phenotype, rescue experiment, combined with genome-wide expression profiling","pmids":["16697960"],"is_preprint":false},{"year":2008,"finding":"NKX2.2 mediates oncogenic transformation in Ewing's sarcoma solely through transcriptional repression: its DNA-binding and repressor domains are required for oncogenesis while its transcriptional activation domain is dispensable. NKX2.2 recruits TLE (Groucho) and HDAC co-repressors, and blockade of TLE or HDAC function inhibits the transformed phenotype. ChIP-chip shows NKX2.2 directly binds and represses target genes.","method":"Structure-function mutagenesis, microarray, ChIP-chip, pharmacological inhibition of TLE/HDAC, RNAi","journal":"PLoS One","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — structure-function mutagenesis combined with ChIP-chip and pharmacological rescue, multiple orthogonal methods in one study","pmids":["18414662"],"is_preprint":false},{"year":2011,"finding":"Nkx2.2 is part of a large repression complex in pancreatic beta cells that includes DNMT3a, Grg3, and HDAC1. The TN (tinman) domain of Nkx2.2 is required for interaction with Grg3; mutation of the TN domain abolishes Grg3 interaction, disrupts beta-cell specification, and causes ectopic Arx expression leading to beta-to-alpha cell transdifferentiation. Nkx2.2 preferentially recruits Grg3 and HDAC1 to the methylated Arx promoter in beta cells. Subsequent removal of Arx in TN-mutant mice reverts the beta-to-alpha cell conversion.","method":"Co-immunoprecipitation, ChIP, endogenous TN-domain point mutation knock-in mice, DNMT3a beta-cell-specific KO, Arx conditional deletion rescue","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — co-IP, ChIP, multiple knock-in/KO models with rescue, multiple orthogonal methods in one study","pmids":["22056672"],"is_preprint":false},{"year":2014,"finding":"Nkx2.2 directly binds to the Pdgfra promoter and represses its expression, thereby acting as a timing switch for oligodendrocyte differentiation. Induced Nkx2.2 expression in early OPCs causes precocious oligodendrocyte differentiation; conditional ablation delays maturation. Genetic ablation of Pdgfra mimics Nkx2.2 overexpression in accelerating OPC differentiation.","method":"ChIP, conditional KO, gain-of-function overexpression in OPCs, genetic epistasis with Pdgfra KO","journal":"Development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct promoter binding by ChIP, conditional KO and OE with phenotype, genetic epistasis","pmids":["24449836"],"is_preprint":false},{"year":2003,"finding":"Nkx2.2 forms a physical protein complex with Olig2 in mammalian cells and in yeast two-hybrid assay; this interaction is specific (Olig2 does not bind Nkx6.1; Nkx2.2 does not bind NeuroD). Deletion mapping showed the physical complex is insufficient for oligodendrocyte progenitor induction but may mediate the cross-repressive interaction establishing the pMN-p3 boundary.","method":"Co-immunoprecipitation in mammalian cells, yeast two-hybrid, deletion mapping","journal":"Journal of Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal protein interaction assays (mammalian Co-IP + yeast two-hybrid), single lab, interaction shown but functional sufficiency was negative","pmids":["14573534"],"is_preprint":false},{"year":2003,"finding":"Lmx1b and Pet-1 act downstream of Nkx2.2 in specifying the serotonergic (5-HT) neurotransmitter phenotype; combined ectopic expression of Lmx1b, Pet-1, and Nkx2.2 drives 5-HT differentiation in the dorsal spinal cord where Nkx2.2 is normally expressed, establishing a molecular pathway sufficient to specify serotonergic identity.","method":"Loss-of-function mouse genetics (Lmx1b null, Nkx2.2 null), ectopic expression in chick spinal cord, epistasis analysis","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis, in vivo gain-of-function sufficient to specify cell fate, multiple KO models","pmids":["14602809"],"is_preprint":false},{"year":2004,"finding":"Pax4 genetically interacts with Nkx2.2 to initiate pancreatic beta-cell differentiation; loss of Pax4 prevents expression of Pdx1, HB9, and insulin in beta-cell precursors, and this role is accomplished via genetic interaction with Nkx2.2.","method":"Loss-of-function mouse genetics (Pax4 KO), immunohistochemistry, epistasis analysis with Nkx2.2","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis, single lab, KO phenotype with marker analysis","pmids":["14729487"],"is_preprint":false},{"year":2005,"finding":"Nkx2.2 represses myelin basic protein (MBP) gene expression in oligodendrocyte progenitors by binding two regulatory elements in the MBP promoter, blocking Puralpha binding, and recruiting an HDAC1-mSin3A co-repressor complex; the transcription factor Sp1 competes off Nkx2.2 from its binding site and reverses this repression.","method":"In vitro DNA binding assay (EMSA), reporter assays, co-immunoprecipitation, chromatin immunoprecipitation","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro binding, ChIP, co-IP identifying corepressor complex, multiple orthogonal methods in one study","pmids":["15695521"],"is_preprint":false},{"year":2006,"finding":"Nkx2.2 directly occupies the insulin gene control region in intact beta cells and also occupies the IAPP, pax-4, and glucokinase control sequences in vivo. In vitro DNA-binding and transient transfection assays confirmed Nkx2.2 binding and its effect on insulin gene expression.","method":"Chromatin immunoprecipitation (ChIP) in beta cells, EMSA, transient transfection reporter assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP demonstrating in vivo occupancy, EMSA for direct binding, reporter assays in same study","pmids":["12426319"],"is_preprint":false},{"year":2006,"finding":"PDX-1, FoxA2, and Nkx2.2 directly bind to the conserved region 3 (bp -8118 to -7750) of the mafA promoter in vivo, and Nkx2.2 mediates activation of this region; MafA expression is undetected in Nkx2.2-null pancreas.","method":"ChIP, reporter assays with mutational analysis, siRNA knockdown, Nkx2.2 null mouse analysis","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP for in vivo binding, mutational analysis, KO confirmation, multiple orthogonal methods","pmids":["16847327"],"is_preprint":false},{"year":2007,"finding":"Nkx2.2-repressor activity (Nkx2.2-Engrailed repressor derivative) is sufficient to fully rescue glucagon-producing alpha-cells and partially rescue insulin-producing beta-cells in Nkx2.2-null mice. Insulin-positive rescued cells lack mature beta-cell markers MafA and Glut2, indicating additional activator functions are required for maturation. Grg3 is highly expressed in embryonic pancreas and physically interacts with Nkx2.2 through its TN domain.","method":"Transgenic dominant-derivative mouse lines, immunohistochemistry, co-immunoprecipitation","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — transgenic rescue experiment with defined functional readout plus co-IP of TN-Grg3 interaction","pmids":["17202186"],"is_preprint":false},{"year":2007,"finding":"Nkx2.2 is required for maintenance and function of the mature beta cell; expressing a repressor derivative of Nkx2.2 in mature beta cells disrupts endogenous Nkx2.2 and causes downregulation of MafA and Glut2, reduced insulin gene expression and pancreatic insulin content, impaired insulin secretion, and glucose intolerance.","method":"Transgenic mice expressing Nkx2.2-repressor derivative in mature beta cells, glucose tolerance tests, insulin secretion assays, marker expression analysis","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic dominant-negative approach, multiple functional readouts, single lab","pmids":["17456846"],"is_preprint":false},{"year":2007,"finding":"Nkx2.2 regulates cell fate choices within the intestinal enteroendocrine population; Nkx2.2-null mice lack or have reduced several hormone-producing enteroendocrine cell populations with a corresponding increase in ghrelin cells, and Nkx2.2 appears to function upstream of Pax6 in intestinal cell fate (Pax6 expression is decreased in Nkx2.2-null intestine).","method":"Nkx2.2 null mouse genetics, immunohistochemistry, marker expression analysis, epistasis with Pax6","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined lineage phenotype, pathway placement via epistasis, single lab","pmids":["18022152"],"is_preprint":false},{"year":2009,"finding":"Nkx2.2 cooperatively activates NeuroD1 transcription with Ngn3 in endocrine progenitor cells and maintains NeuroD1 expression in mature beta cells. Nkx2.2 regulates NeuroD1 through two independent promoter elements: one directly bound and activated by Nkx2.2, and one regulated indirectly. Nkx2.2 activity is required to facilitate Ngn3-mediated NeuroD1 activation.","method":"Reporter assays, ChIP, Nkx2.2 KO mouse analysis, zebrafish knockdown, promoter deletion analysis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct promoter binding by ChIP, multiple KO/KD models, reporter assays with two species validation","pmids":["19759004"],"is_preprint":false},{"year":2009,"finding":"Nkx2.2 can bind to and activate the ghrelin promoter; the region -619 to -488 bp upstream of the translational start site is necessary for repression of ghrelin in alphaTC1 and betaTC6 cells. Upregulation of ghrelin in Nkx2.2-null mice is not due to loss of ghrelin promoter repression in non-ghrelin islet cells.","method":"Reporter assays, ChIP, EMSA, Nkx2.2 null mouse analysis","journal":"Molecular Endocrinology","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — direct binding by EMSA and ChIP, reporter assay, KO validation, single lab","pmids":["19965928"],"is_preprint":false},{"year":2011,"finding":"Nkx2.2 transcription factor binds to the Sirt2 promoter via HDAC-1 in oligodendroglial precursor cells and negatively regulates Sirt2 expression. HDAC-1 knockdown attenuates Nkx2.2 binding capacity and releases Sirt2 repression. Nkx2.2 overexpression down-regulates Sirt2 and delays CG4 cell differentiation.","method":"ChIP, HDAC-1 RNAi, Nkx2.2 overexpression in CG4 oligodendroglial precursor cells","journal":"Journal of Molecular Cell Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct binding, RNAi functional validation, single lab","pmids":["21669943"],"is_preprint":false},{"year":2000,"finding":"The homeodomain of Nkx2.2 contains two cooperatively acting monopartite nuclear localization signals (NLS): proximal NLS (KKRKRR) at the N-terminus of the homeodomain and distal NLS (RYKMKRAR) at its C-terminus. Each NLS alone is sufficient but inefficient for nuclear transport; both act cooperatively for complete nuclear import.","method":"Deletion mutant analysis, nuclear localization assays","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deletion mutagenesis with functional localization readout, single lab","pmids":["10772886"],"is_preprint":false},{"year":2016,"finding":"Nuclear import of Nkx2-2 is mediated by multiple pathways: importin α1 interacts with Nkx2-2 and transports it together with importin β1 in vitro; importin β1 and importin 13 also directly interact with Nkx2-2 and transport it in vitro. Mutation of NLS1 or NLS2 has no effect on interaction with importin α1 or importin 13, but significantly reduces binding to importin β1.","method":"GST pulldown, in vitro nuclear import assay, importin β1 RNAi, Bimax2 overexpression, NLS mutagenesis","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple in vitro interaction and import assays, mutagenesis, single lab","pmids":["27956177"],"is_preprint":false},{"year":2017,"finding":"Nkx2.2 acts downstream of Neurog3 in the endocrine progenitor lineage for beta cell differentiation; conditional ablation of Nkx2.2 specifically in Neurog3+ progenitors recapitulates the Nkx2.2 null beta cell phenotype despite maintenance of many beta cell transcriptional network components, demonstrating Nkx2.2 has essential activities within the endocrine progenitor population beyond its earlier pancreatic progenitor role.","method":"Conditional KO using Neurog3-Cre, comparison with germline Nkx2.2 null, gene expression analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with stage-specific phenotype, rigorous comparison with germline KO, multiple markers","pmids":["28071588"],"is_preprint":false},{"year":2010,"finding":"In mice lacking both Nkx2.2 and Nkx2.9, the presumptive p3 domain progenitors convert to motor neurons and never acquire V3 interneuron fate, demonstrating that Nkx2 transcription factors repress the motor neuron lineage program (including Olig2) to establish V3 progenitor cells. Additionally, combined loss of Nkx2.2 and Nkx2.9 results in a smaller and functionally impaired floor plate causing severe commissural axon pathfinding defects.","method":"Double-mutant mouse genetics, lineage analysis, electrophysiology, immunohistochemistry","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-mutant epistasis, multiple cellular phenotypes, functional electrophysiology readout","pmids":["21068056"],"is_preprint":false},{"year":2020,"finding":"NKX2-2 regulates oligodendrocyte differentiation through domain-specific interactions with distinct transcriptional corepressors: the N-terminal Tinman (TN) domain recruits GRG3, and the C-terminal domain recruits HDAC1 and DNMT3A. Both domains synergistically promote OL differentiation in vivo. The NK2-specific domain suppresses the function of the C-terminal domain in OL differentiation.","method":"Coimmunoprecipitation, in ovo electroporation in chick spinal cord, immunofluorescence, domain deletion analysis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — co-IP identifying cofactors, in vivo gain-of-function with domain mutants, multiple orthogonal methods","pmids":["31932307"],"is_preprint":false},{"year":2011,"finding":"Nkx2.2 and Arx genetically interact in pancreatic endocrine progenitors; in the Nkx2.2-null context, Arx is necessary for upregulation of ghrelin mRNA in epsilon cells but not for the expansion of the ghrelin cell population. In the absence of Arx, Nkx2.2 becomes essential for repression of somatostatin gene expression, and Arx is required in Neurog3+ endocrine progenitors.","method":"Compound conditional KO mouse genetics (Nkx2.2 null; Arx conditional deletion), immunohistochemistry, gene expression analysis","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — compound genetic analysis establishing interaction, defined cellular phenotypes, single lab","pmids":["21856296"],"is_preprint":false},{"year":2014,"finding":"Ceramide galactosyltransferase (CGT) expression in oligodendrocytes is positively regulated by Nkx2.2 at the promoter level; Nkx2.2 strongly activates the CGT promoter in reporter assays, and this activation is cancelled by co-expression of OLIG2, which binds a repressive element in the first intron of CGT.","method":"Reporter assay (luciferase), transcription factor co-expression in oligodendroglioma cells, identification of binding element","journal":"Glycobiology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — reporter assay only, single lab, no direct binding confirmed for NKX2.2 to CGT in this study","pmids":["24821492"],"is_preprint":false},{"year":2016,"finding":"Nkx2.2 regulates enteroendocrine cell specification at multiple stages in the intestine; serotonin-producing enterochromaffin cells are most severely reduced in all Nkx2.2 mutant conditions. The transcription factor Lmx1a is expressed in enterochromaffin cells downstream of Nkx2.2, and Lmx1a-deficient mice have reduced expression of Tph1, the rate-limiting enzyme for serotonin biosynthesis.","method":"Stage- and cell type-specific Nkx2.2 conditional KO, lineage tracing, Lmx1a KO mouse analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple conditional KO models, genetic epistasis establishing Lmx1a downstream of Nkx2.2, defined lineage phenotype","pmids":["27287799"],"is_preprint":false},{"year":2023,"finding":"The NK2-specific domain (SD) of NKX2.2 is required for beta cell-specific functions: SD mutation in mice prevents developmental progression of beta cell precursors into mature insulin-expressing beta cells, causing neonatal diabetes, and impairs a subset of adult beta cell gene expression programs. However, the SD is entirely dispensable for NKX2.2-dependent CNS cell type development, demonstrating tissue-specific domain requirement. SD-dependent interactions occur with components of chromatin remodelers and the nuclear pore complex.","method":"Endogenous SD point-mutation knock-in mice, gene expression analysis, co-immunoprecipitation for chromatin remodeler interactions","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — endogenous domain mutation with tissue-specific phenotype, multiple functional readouts, interaction data","pmids":["37364986"],"is_preprint":false},{"year":2025,"finding":"NKX2.2 is critical for pancreatic alpha cell identity by directly activating alpha-cell genes and repressing alternate islet cell fate genes. KLF4 is enriched in alpha cells, co-occupies NKX2.2-bound alpha-cell promoters, is necessary for NKX2.2 promoter occupancy in alpha cells, and co-regulates NKX2.2 alpha-cell transcriptional targets. Overexpression of Klf4 in beta cells is sufficient to manipulate chromatin accessibility and increase NKX2.2 binding at alpha-cell-specific promoter sites.","method":"ChIP-seq, ATAC-seq, conditional KO (Nkx2.2 and Klf4), Klf4 overexpression in beta cells, gene expression analysis","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP-seq for direct binding, ATAC-seq for chromatin remodeling, KO and OE experiments with defined phenotypes, single recent lab","pmids":["39797760"],"is_preprint":false},{"year":2025,"finding":"CHD4 (chromodomain helicase DNA-binding protein 4) is an NKX2.2 interacting partner in beta cells identified by proteomics; CHD4 and NKX2.2 cooperatively bind to and repress non-beta cell genes, including Kcnj5 (encoding GIRK4 potassium channel). Deletion of Chd4 in beta cells causes diabetes with disrupted islet integrity, impaired calcium signaling, and downregulation of beta cell regulatory genes; aberrant GIRK4 expression causes impaired glucose-stimulated insulin secretion.","method":"Unbiased proteomics screen, co-immunoprecipitation, Chd4 conditional KO (beta-cell specific), ChIP, calcium imaging, glucose-stimulated insulin secretion assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomics + co-IP identification, conditional KO with functional readout, ChIP for co-occupancy; preprint, not yet peer-reviewed","pmids":["40667117"],"is_preprint":true},{"year":2024,"finding":"NKX2-2 represses proneural gene NEUROG2 by two distinct mechanisms in rodent versus human spinal progenitors: in rodents, NKX2-2 represses Olig2 and the motor neuron lineage through its tinman domain (leading to loss of Neurog2); in human vpMN progenitors, NKX2-2 represses NEUROG2 but not OLIG2, allowing motor neurogenesis to proceed in a delayed manner. Ectopic expression of tinman-mutant Nkx2-2 in mouse pMNs phenocopies human vpMNs.","method":"In vivo and in vitro gain/loss-of-function, ectopic expression of tinman domain mutants in mouse, comparative human vs rodent neural progenitor analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-specific mutant with in vivo phenotype, comparative species analysis; preprint, not peer-reviewed","pmids":["39415990"],"is_preprint":true},{"year":2015,"finding":"In Ewing's sarcoma, NKX2-2 represses cell adhesion and extracellular matrix organization genes; NKX2-2-depleted cells form more focal adhesions, organized actin stress fibers, spread over wider area, and display increased migration and substrate adhesion. NKX2-2 specifically represses the actin-stabilizing protein zyxin.","method":"RNA-seq after NKX2-2 knockdown, cell adhesion/migration assays, immunofluorescence for actin and focal adhesions","journal":"Genes & Cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transcriptome-wide RNAseq, cellular functional assays, single lab","pmids":["26000096"],"is_preprint":false},{"year":2010,"finding":"NKX2.2 overexpression in glioblastoma-derived glioma-initiating cells (GICs) induces oligodendroglial differentiation and suppresses self-renewal capacity; conversely, Nkx2.2 downregulation in mouse neural progenitor cells accelerates GBM formation. Downregulation of NKX2.2 correlates with increased tumor malignancy in both mouse models and human specimens.","method":"Overexpression in GICs, loss-of-function in mouse NPCs (in vivo), neurosphere self-renewal assays, differentiation marker analysis","journal":"Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain and loss-of-function with defined cellular phenotype, in vivo confirmation, single lab","pmids":["21169405"],"is_preprint":false},{"year":2024,"finding":"Nkx2.2 and Zfp488 act as transcriptional activators (in addition to their known repressor roles) for the G protein-coupled receptor Gpr37 in differentiating oligodendrocytes; both transcription factors bind a regulatory region downstream of the Gpr37 gene in vivo and cooperate with Sox10 to activate Gpr37 expression, which modulates myelination.","method":"Overexpression in CG4 cells, Nkx2.2-deficient mouse analysis, ChIP for in vivo binding, reporter assays","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo ChIP, KO mouse validation, reporter assays, single lab","pmids":["38546197"],"is_preprint":false},{"year":2021,"finding":"Nkx2-2-expressing taste cells in endoderm-derived circumvallate and foliate papillae are committed to the type III taste cell lineage; Nkx2-2 knockout neonatal mice do not express key type III taste cell marker genes, while type I and II marker genes are unaffected. Lineage tracing showed Nkx2-2+ cells differentiate into type III but not type II or I cells in posterior taste papillae.","method":"Conditional lineage tracing (Nkx2-2-Cre), Nkx2-2 KO mouse analysis, single-cell RNA-seq, in situ hybridization, immunostaining","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — lineage tracing plus KO with defined cell-type-specific phenotype, multiple orthogonal methods","pmids":["34097879"],"is_preprint":false},{"year":2014,"finding":"Nkx2.2-expressing perineurial glia in mice are CNS-derived and essential for motor nerve development and Schwann cell differentiation; in mice lacking Nkx2.2, motor nerve development is impaired.","method":"Nkx2.2:EGFP transgenic reporter, Nkx2.2 null mouse analysis, RNA expression analysis, antibody labeling","journal":"Developmental Dynamics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined cellular phenotype, transgenic reporter line to trace cell origin, single lab","pmids":["24979729"],"is_preprint":false},{"year":2023,"finding":"A frameshift mutation (c.772delC, p.Q258SFs*59) in the NKX2-2 homeodomain results in an elongated protein that lacks normal DNA binding activity and transcriptional function, establishing that DNA binding by NKX2-2 is required for its normal transcription factor activity. Structural analysis indicated alterations in tertiary structure contributing to dysfunction.","method":"Functional transactivation assay, DNA binding assay, nuclear localization assay, protein structural modeling of mutant","journal":"Acta Diabetologica","confidence":"Medium","confidence_rationale":"Tier 1-2 / Weak — direct functional assays on disease-causing mutation, single case/lab, no independent replication","pmids":["37821536"],"is_preprint":false}],"current_model":"NKX2-2 is a homeodomain transcription factor that functions primarily as a transcriptional repressor (recruiting corepressor complexes including Grg3/TLE, HDAC1, and DNMT3A via its TN and C-terminal domains) but also as a context-dependent activator, acting downstream of Sonic hedgehog signaling to specify distinct progenitor cell identities in the ventral neural tube, pancreatic islet (beta, alpha, and epsilon cells), intestinal enteroendocrine cells, and oligodendrocytes; its beta cell-specific functions are mediated through the NK2-specific domain which interacts with chromatin remodelers, while its CNS functions are largely domain-independent, and in Ewing's sarcoma it acts as an obligatory downstream effector of EWS/FLI that drives oncogenesis through transcriptional repression of differentiation and mesenchymal genes."},"narrative":{"mechanistic_narrative":"NKX2-2 is a homeodomain transcription factor that interprets graded developmental signals to specify cell identity in multiple lineages, acting predominantly as a transcriptional repressor but also as a context-dependent activator [PMID:10217145, PMID:18414662, PMID:19759004]. In the ventral neural tube it functions downstream of Sonic hedgehog to specify V3 interneuron fate, and together with the paralog Nkx2.9 it represses the motor neuron program (including Olig2) to establish the p3 progenitor domain [PMID:10217145, PMID:21068056]; it likewise controls the timing of oligodendrocyte differentiation and maturation, in part by directly binding and repressing the Pdgfra promoter [PMID:11526078, PMID:24449836]. In the pancreatic islet, NKX2-2 is required for terminal differentiation and maintenance of insulin-producing beta cells and for alpha- and epsilon-cell identity, operating downstream of Neurog3 in the endocrine progenitor lineage and upstream of Nkx6.1 [PMID:9584121, PMID:11076772, PMID:28071588, PMID:39797760]. It directly occupies the insulin, IAPP, glucokinase, mafA, and NeuroD1 control regions, activating beta-cell maturation genes while repressing alternate-fate genes such as Arx and ghrelin [PMID:12426319, PMID:16847327, PMID:19759004, PMID:22056672]. Repressive function is executed by recruiting corepressor complexes: the N-terminal TN (tinman) domain binds Grg3/TLE, while a C-terminal region recruits HDAC1 and DNMT3A, directing repression of methylated targets such as the Arx promoter to prevent beta-to-alpha transdifferentiation [PMID:22056672, PMID:31932307]. The NK2-specific domain confers beta-cell-specific functions through interactions with chromatin remodelers and the nuclear pore complex but is dispensable for CNS roles, defining tissue-specific domain requirements [PMID:37364986]. NKX2-2 also directs intestinal enteroendocrine cell fate and type III taste cell commitment [PMID:27287799, PMID:34097879]. In Ewing's sarcoma, NKX2-2 is an obligatory transcriptional target and downstream effector of the EWS/FLI fusion that drives oncogenesis solely through its repressor activity, silencing differentiation, cell adhesion, and extracellular matrix genes [PMID:16697960, PMID:18414662, PMID:26000096]. A frameshift mutation in the NKX2-2 homeodomain that abolishes DNA binding causes neonatal diabetes [PMID:37821536].","teleology":[{"year":1998,"claim":"Established that NKX2-2 is required for terminal differentiation of insulin-producing beta cells, defining its first developmental requirement.","evidence":"Null mouse genetics with islet marker analysis","pmids":["9584121"],"confidence":"High","gaps":["Did not identify direct target genes","Mechanism of arrest (repressor vs activator) not resolved"]},{"year":1999,"claim":"Showed NKX2-2 is a primary interpreter of graded Shh signaling in the neural tube, converting a signaling gradient into V3 interneuron identity rather than acting through Pax6.","evidence":"Nkx2.2 null mice, immunohistochemistry, epistasis with Pax6 mutants","pmids":["10217145"],"confidence":"High","gaps":["Direct transcriptional targets in neural tube not defined","Did not address downstream effector genes"]},{"year":2000,"claim":"Defined the nuclear import determinants of NKX2-2, mapping two cooperative NLS within the homeodomain.","evidence":"Deletion mutant analysis and nuclear localization assays","pmids":["10772886"],"confidence":"Medium","gaps":["Import receptors not identified at this stage","Single-lab functional readout"]},{"year":2000,"claim":"Placed Nkx6.1 genetically downstream of NKX2-2 in beta-cell differentiation, ordering the islet transcription factor hierarchy.","evidence":"Double-mutant mouse epistasis","pmids":["11076772"],"confidence":"High","gaps":["Direct vs indirect regulation of Nkx6.1 unresolved"]},{"year":2001,"claim":"Demonstrated NKX2-2 cooperates with Olig2 as a repressor to drive oligodendrocyte differentiation and that it controls OL maturation in vivo.","evidence":"Ectopic expression in chick spinal cord, null mouse genetics, reporter assays","pmids":["11567617","11526078"],"confidence":"High","gaps":["Direct OL target genes not yet identified","Nature of the Olig2 interaction unresolved"]},{"year":2003,"claim":"Showed NKX2-2 physically complexes with Olig2 and placed it upstream of serotonergic specification factors, linking protein interaction to lineage cross-repression.","evidence":"Co-IP, yeast two-hybrid, deletion mapping; ectopic expression with Lmx1b/Pet-1 in chick","pmids":["14573534","14602809"],"confidence":"Medium","gaps":["Olig2 complex shown insufficient for OPC induction","Functional relevance of physical interaction not established"]},{"year":2006,"claim":"Identified direct NKX2-2 occupancy at islet target promoters (insulin, IAPP, pax-4, glucokinase) and at the mafA enhancer, providing the first direct binding evidence in beta cells.","evidence":"ChIP in beta cells, EMSA, reporter assays, Nkx2.2-null analysis","pmids":["12426319","16847327"],"confidence":"High","gaps":["Cofactors at these sites not yet defined","Activator vs repressor mode site-specific"]},{"year":2006,"claim":"Established NKX2-2 as an obligatory downstream target of EWS/FLI required for Ewing's sarcoma tumorigenesis, extending its role beyond development to oncogenesis.","evidence":"RNAi knockdown, rescue, microarray profiling","pmids":["16697960"],"confidence":"High","gaps":["Mechanism of transformation (repressor vs activator) not yet resolved","Direct oncogenic targets unidentified"]},{"year":2007,"claim":"Defined NKX2-2 repressor activity as sufficient to rescue alpha and partial beta-cell fate, and showed it is required to maintain mature beta-cell function, linking transcriptional repression to islet identity and physiology.","evidence":"Transgenic Engrailed-repressor and dominant-derivative mice, glucose tolerance/insulin secretion assays, co-IP of Grg3","pmids":["17202186","17456846","18022152"],"confidence":"High","gaps":["Activator functions needed for full beta-cell maturation not identified","Distinction between developmental and maintenance targets incomplete"]},{"year":2008,"claim":"Resolved the mechanism of NKX2-2-driven transformation in Ewing's sarcoma as repression-only, mapping DNA-binding and repressor domains as essential and implicating TLE/HDAC corepressors.","evidence":"Structure-function mutagenesis, ChIP-chip, pharmacological TLE/HDAC inhibition, RNAi","pmids":["18414662"],"confidence":"High","gaps":["Specific repressed differentiation targets not fully enumerated here"]},{"year":2009,"claim":"Revealed NKX2-2 dual activity in islet cells: direct cooperative activation of NeuroD1 with Ngn3 and direct binding/regulation of the ghrelin promoter.","evidence":"ChIP, EMSA, reporter assays, KO mouse and zebrafish knockdown","pmids":["19759004","19965928"],"confidence":"High","gaps":["Switch between activation and repression modes mechanistically unexplained","Cofactor determinants of mode not identified"]},{"year":2011,"claim":"Assembled the NKX2-2 corepressor complex (DNMT3a, Grg3, HDAC1) and showed TN-domain recruitment of Grg3 directs Arx-promoter repression to prevent beta-to-alpha transdifferentiation, mechanistically linking corepressor recruitment to cell-identity maintenance.","evidence":"Co-IP, ChIP, TN-domain knock-in mice, DNMT3a beta-cell KO, Arx conditional rescue","pmids":["22056672","21856296"],"confidence":"High","gaps":["How DNA methylation status is established at targets unresolved","Full complex stoichiometry not defined"]},{"year":2011,"claim":"Extended the HDAC1-dependent repression mechanism to oligodendroglia, showing NKX2-2 represses Sirt2 via HDAC1 to time differentiation.","evidence":"ChIP, HDAC1 RNAi, overexpression in CG4 cells","pmids":["21669943"],"confidence":"Medium","gaps":["Single-lab cell-line evidence","In vivo relevance of Sirt2 regulation untested"]},{"year":2014,"claim":"Identified Pdgfra as a direct NKX2-2 repression target acting as a timing switch for oligodendrocyte differentiation.","evidence":"ChIP, conditional KO and OE in OPCs, genetic epistasis with Pdgfra KO","pmids":["24449836"],"confidence":"High","gaps":["Corepressors at Pdgfra promoter not defined"]},{"year":2015,"claim":"Showed NKX2-2 represses cell adhesion and ECM genes (including zyxin) in Ewing's sarcoma, linking its repressor activity to control of migration and adhesion.","evidence":"RNA-seq after knockdown, adhesion/migration assays, immunofluorescence","pmids":["26000096"],"confidence":"Medium","gaps":["Direct binding to adhesion gene loci not all confirmed","Single lab"]},{"year":2016,"claim":"Identified the importins (alpha1, beta1, importin 13) mediating NKX2-2 nuclear import and the differential NLS dependence among pathways.","evidence":"GST pulldown, in vitro import assays, importin RNAi, NLS mutagenesis","pmids":["27956177"],"confidence":"Medium","gaps":["In vivo redundancy of import pathways untested","Single lab in vitro"]},{"year":2016,"claim":"Defined NKX2-2 control of intestinal enteroendocrine fate at multiple stages, placing Lmx1a downstream in the enterochromaffin/serotonin program.","evidence":"Stage-specific conditional KO, lineage tracing, Lmx1a KO","pmids":["27287799"],"confidence":"High","gaps":["Direct intestinal target genes not mapped"]},{"year":2017,"claim":"Demonstrated NKX2-2 has essential, stage-specific functions within the Neurog3+ endocrine progenitor population, distinct from earlier pancreatic progenitor roles.","evidence":"Neurog3-Cre conditional KO vs germline null, expression analysis","pmids":["28071588"],"confidence":"High","gaps":["Stage-specific direct targets not delineated"]},{"year":2020,"claim":"Mapped domain-specific corepressor recruitment in oligodendrocytes: TN domain to GRG3, C-terminus to HDAC1/DNMT3A, with synergy and intramolecular suppression by the NK2 domain.","evidence":"Co-IP, in ovo electroporation, domain deletion analysis","pmids":["31932307"],"confidence":"High","gaps":["Direct OL targets of each domain not enumerated"]},{"year":2021,"claim":"Identified NKX2-2 as the commitment factor for the type III taste cell lineage in posterior taste papillae, broadening its lineage-specification roles.","evidence":"Lineage tracing, KO analysis, single-cell RNA-seq, in situ hybridization","pmids":["34097879"],"confidence":"High","gaps":["Direct taste-lineage target genes unknown"]},{"year":2023,"claim":"Established tissue-specific domain requirement: the NK2-specific domain is essential for beta-cell maturation (its mutation causes neonatal diabetes) but dispensable for CNS roles, and acts via chromatin remodeler and nuclear pore interactions.","evidence":"Endogenous SD point-mutant knock-in mice, expression analysis, co-IP; and disease-mutation functional assays","pmids":["37364986","37821536"],"confidence":"High","gaps":["Identity of SD-dependent chromatin remodelers not fully defined in the SD study","Disease mutation evidence from a single case"]},{"year":2025,"claim":"Defined NKX2-2 cofactor logic for alpha-cell identity (KLF4 directs its promoter occupancy and chromatin accessibility) and beta-cell repression (CHD4 cooperates to silence non-beta genes), revealing how cofactors steer target selection.","evidence":"ChIP-seq, ATAC-seq, conditional KO and OE; proteomics, co-IP, conditional KO, calcium imaging (CHD4 preprint)","pmids":["39797760","40667117"],"confidence":"High","gaps":["CHD4 findings are from a preprint not yet peer-reviewed","How cofactor availability is set per cell type unresolved"]},{"year":null,"claim":"How NKX2-2 switches between repressor and activator modes at individual loci, and how cofactor/chromatin context selects tissue-specific target sets, remains incompletely defined.","evidence":"","pmids":[],"confidence":"High","gaps":["No unifying biochemical model for activator-vs-repressor switching","Structural basis of domain-specific cofactor selection unresolved","Genome-wide direct targets across all lineages not comprehensively integrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,6,13,18,30,38]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[12,13,38]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[21,22]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[7,13,30]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[6,13,18,30]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,4,23,28,36]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,6,33,38]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7,25,30]}],"complexes":["NKX2-2-Grg3-HDAC1-DNMT3A corepressor complex","HDAC1-mSin3A corepressor complex"],"partners":["TLE/GRG3","HDAC1","DNMT3A","OLIG2","CHD4","KLF4","IMPORTIN BETA1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O95096","full_name":"Homeobox protein Nkx-2.2","aliases":["Homeobox protein NK-2 homolog B"],"length_aa":273,"mass_kda":30.1,"function":"Transcriptional activator involved in the development of insulin-producting beta cells in the endocrine pancreas (By similarity). May also be involved in specifying diencephalic neuromeric boundaries, and in controlling the expression of genes that play a role in axonal guidance. Binds to elements within the NEUROD1 promoter (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O95096/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NKX2-2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NKX2-2","total_profiled":1310},"omim":[{"mim_id":"617138","title":"SKI FAMILY TRANSCRIPTIONAL COREPRESSOR 2; SKOR2","url":"https://www.omim.org/entry/617138"},{"mim_id":"607808","title":"NK2 HOMEOBOX 4; NKX2-4","url":"https://www.omim.org/entry/607808"},{"mim_id":"606624","title":"NEUROGENIN 2; NEUROG2","url":"https://www.omim.org/entry/606624"},{"mim_id":"606386","title":"OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2; OLIG2","url":"https://www.omim.org/entry/606386"},{"mim_id":"604612","title":"NK2 HOMEOBOX 2; NKX2-2","url":"https://www.omim.org/entry/604612"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":41.9}],"url":"https://www.proteinatlas.org/search/NKX2-2"},"hgnc":{"alias_symbol":["NKX2.2"],"prev_symbol":["NKX2B"]},"alphafold":{"accession":"O95096","domains":[{"cath_id":"1.10.10.60","chopping":"134-189","consensus_level":"medium","plddt":96.7921,"start":134,"end":189}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95096","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95096-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95096-F1-predicted_aligned_error_v6.png","plddt_mean":63.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NKX2-2","jax_strain_url":"https://www.jax.org/strain/search?query=NKX2-2"},"sequence":{"accession":"O95096","fasta_url":"https://rest.uniprot.org/uniprotkb/O95096.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95096/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95096"}},"corpus_meta":[{"pmid":"10217145","id":"PMC_10217145","title":"Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10217145","citation_count":605,"is_preprint":false},{"pmid":"9584121","id":"PMC_9584121","title":"Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9584121","citation_count":513,"is_preprint":false},{"pmid":"11567617","id":"PMC_11567617","title":"The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2.","date":"2001","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/11567617","citation_count":478,"is_preprint":false},{"pmid":"11076772","id":"PMC_11076772","title":"Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11076772","citation_count":427,"is_preprint":false},{"pmid":"11526078","id":"PMC_11526078","title":"Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11526078","citation_count":315,"is_preprint":false},{"pmid":"16697960","id":"PMC_16697960","title":"Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.","date":"2006","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/16697960","citation_count":297,"is_preprint":false},{"pmid":"15519240","id":"PMC_15519240","title":"Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS.","date":"2004","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/15519240","citation_count":245,"is_preprint":false},{"pmid":"11830569","id":"PMC_11830569","title":"Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11830569","citation_count":177,"is_preprint":false},{"pmid":"22056672","id":"PMC_22056672","title":"Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming.","date":"2011","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/22056672","citation_count":165,"is_preprint":false},{"pmid":"15698615","id":"PMC_15698615","title":"Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.","date":"2005","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15698615","citation_count":162,"is_preprint":false},{"pmid":"22446943","id":"PMC_22446943","title":"NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.","date":"2012","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22446943","citation_count":157,"is_preprint":false},{"pmid":"28071588","id":"PMC_28071588","title":"Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28071588","citation_count":156,"is_preprint":false},{"pmid":"26847175","id":"PMC_26847175","title":"Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.","date":"2016","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/26847175","citation_count":148,"is_preprint":false},{"pmid":"14602809","id":"PMC_14602809","title":"Lmx1b, Pet-1, and Nkx2.2 coordinately specify serotonergic neurotransmitter phenotype.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14602809","citation_count":140,"is_preprint":false},{"pmid":"24449836","id":"PMC_24449836","title":"Genetic evidence that Nkx2.2 and Pdgfra are major determinants of the timing of oligodendrocyte differentiation in the developing CNS.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24449836","citation_count":125,"is_preprint":false},{"pmid":"9347917","id":"PMC_9347917","title":"Expression patterns of Brx1 (Rieg gene), Sonic hedgehog, Nkx2.2, Dlx1 and Arx during zona limitans intrathalamica and embryonic ventral lateral geniculate nuclear formation.","date":"1997","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9347917","citation_count":121,"is_preprint":false},{"pmid":"18414662","id":"PMC_18414662","title":"EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18414662","citation_count":119,"is_preprint":false},{"pmid":"11262237","id":"PMC_11262237","title":"Distinct sites of origin of oligodendrocytes and somatic motoneurons in the chick spinal cord: oligodendrocytes arise from Nkx2.2-expressing progenitors by a Shh-dependent mechanism.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11262237","citation_count":119,"is_preprint":false},{"pmid":"14729487","id":"PMC_14729487","title":"The concerted activities of Pax4 and Nkx2.2 are essential to initiate pancreatic beta-cell differentiation.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/14729487","citation_count":117,"is_preprint":false},{"pmid":"24411943","id":"PMC_24411943","title":"Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man.","date":"2014","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24411943","citation_count":114,"is_preprint":false},{"pmid":"16847327","id":"PMC_16847327","title":"FoxA2, Nkx2.2, and PDX-1 regulate islet beta-cell-specific mafA expression through conserved sequences located between base pairs -8118 and -7750 upstream from the transcription start site.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16847327","citation_count":102,"is_preprint":false},{"pmid":"25031013","id":"PMC_25031013","title":"The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.","date":"2014","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25031013","citation_count":87,"is_preprint":false},{"pmid":"17456846","id":"PMC_17456846","title":"Nkx2.2 regulates beta-cell function in the mature islet.","date":"2007","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/17456846","citation_count":85,"is_preprint":false},{"pmid":"12426319","id":"PMC_12426319","title":"Transcription factor occupancy of the insulin gene in vivo. Evidence for direct regulation by Nkx2.2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12426319","citation_count":81,"is_preprint":false},{"pmid":"18022152","id":"PMC_18022152","title":"Nkx2.2 regulates cell fate choice in the enteroendocrine cell lineages of the intestine.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18022152","citation_count":80,"is_preprint":false},{"pmid":"19780200","id":"PMC_19780200","title":"Co-localization of Nkx6.2 and Nkx2.2 homeodomain proteins in differentiated myelinating oligodendrocytes.","date":"2010","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/19780200","citation_count":80,"is_preprint":false},{"pmid":"18538132","id":"PMC_18538132","title":"Nkx2.2 antisense RNA overexpression enhanced oligodendrocytic differentiation.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18538132","citation_count":71,"is_preprint":false},{"pmid":"21059263","id":"PMC_21059263","title":"Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21059263","citation_count":71,"is_preprint":false},{"pmid":"21669943","id":"PMC_21669943","title":"Sirt2 is a novel in vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation.","date":"2011","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21669943","citation_count":67,"is_preprint":false},{"pmid":"15048854","id":"PMC_15048854","title":"Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination.","date":"2004","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/15048854","citation_count":63,"is_preprint":false},{"pmid":"17202186","id":"PMC_17202186","title":"Nkx2.2-repressor activity is sufficient to specify alpha-cells and a small number of beta-cells in the pancreatic islet.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17202186","citation_count":61,"is_preprint":false},{"pmid":"15695521","id":"PMC_15695521","title":"Stage-specific expression of myelin basic protein in oligodendrocytes involves Nkx2.2-mediated repression that is relieved by the Sp1 transcription factor.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15695521","citation_count":60,"is_preprint":false},{"pmid":"17146289","id":"PMC_17146289","title":"Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.","date":"2006","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17146289","citation_count":59,"is_preprint":false},{"pmid":"14573534","id":"PMC_14573534","title":"Cross-repressive interaction of the Olig2 and Nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complex.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14573534","citation_count":55,"is_preprint":false},{"pmid":"30376220","id":"PMC_30376220","title":"NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.","date":"2018","source":"Cancer cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/30376220","citation_count":51,"is_preprint":false},{"pmid":"19759004","id":"PMC_19759004","title":"Cooperative transcriptional regulation of the essential pancreatic islet gene NeuroD1 (beta2) by Nkx2.2 and neurogenin 3.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19759004","citation_count":51,"is_preprint":false},{"pmid":"12915306","id":"PMC_12915306","title":"Co-expression pattern of Shh with Prox1 and that of Nkx2.2 with Mash1 in mouse taste bud.","date":"2003","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/12915306","citation_count":45,"is_preprint":false},{"pmid":"27287799","id":"PMC_27287799","title":"The novel enterochromaffin marker Lmx1a regulates serotonin biosynthesis in enteroendocrine cell lineages downstream of Nkx2.2.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27287799","citation_count":43,"is_preprint":false},{"pmid":"21068056","id":"PMC_21068056","title":"The transcription factors Nkx2.2 and Nkx2.9 play a novel role in floor plate development and commissural axon guidance.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21068056","citation_count":42,"is_preprint":false},{"pmid":"26000096","id":"PMC_26000096","title":"EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma.","date":"2015","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26000096","citation_count":40,"is_preprint":false},{"pmid":"21856296","id":"PMC_21856296","title":"Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell development and endocrine hormone expression.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21856296","citation_count":40,"is_preprint":false},{"pmid":"28616785","id":"PMC_28616785","title":"Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.","date":"2017","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28616785","citation_count":38,"is_preprint":false},{"pmid":"16015683","id":"PMC_16015683","title":"Differentiation of embryonic stem cells into insulin-producing cells promoted by Nkx2.2 gene transfer.","date":"2005","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/16015683","citation_count":36,"is_preprint":false},{"pmid":"24979729","id":"PMC_24979729","title":"Mammalian Nkx2.2+ perineurial glia are essential for motor nerve development.","date":"2014","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/24979729","citation_count":35,"is_preprint":false},{"pmid":"18987169","id":"PMC_18987169","title":"Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors.","date":"2008","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18987169","citation_count":32,"is_preprint":false},{"pmid":"31932307","id":"PMC_31932307","title":"The transcription factor NKX2-2 regulates oligodendrocyte differentiation through domain-specific interactions with transcriptional corepressors.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31932307","citation_count":28,"is_preprint":false},{"pmid":"20003319","id":"PMC_20003319","title":"Identification of known and novel pancreas genes expressed downstream of Nkx2.2 during development.","date":"2009","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20003319","citation_count":27,"is_preprint":false},{"pmid":"28864350","id":"PMC_28864350","title":"Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.","date":"2017","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/28864350","citation_count":26,"is_preprint":false},{"pmid":"21880149","id":"PMC_21880149","title":"Arx and Nkx2.2 compound deficiency redirects pancreatic alpha- and beta-cell differentiation to a somatostatin/ghrelin co-expressing cell lineage.","date":"2011","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21880149","citation_count":25,"is_preprint":false},{"pmid":"23494546","id":"PMC_23494546","title":"Generation of mice encoding a conditional allele of Nkx2.2.","date":"2013","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/23494546","citation_count":24,"is_preprint":false},{"pmid":"24835010","id":"PMC_24835010","title":"C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24835010","citation_count":24,"is_preprint":false},{"pmid":"21169405","id":"PMC_21169405","title":"NKX2.2 suppresses self-renewal of glioma-initiating cells.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21169405","citation_count":23,"is_preprint":false},{"pmid":"21415915","id":"PMC_21415915","title":"Ontogenetic distribution of the transcription factor nkx2.2 in the developing forebrain of Xenopus laevis.","date":"2011","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/21415915","citation_count":22,"is_preprint":false},{"pmid":"29713473","id":"PMC_29713473","title":"NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.","date":"2018","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/29713473","citation_count":20,"is_preprint":false},{"pmid":"23996959","id":"PMC_23996959","title":"Nkx2.2:Cre knock-in mouse line: a novel tool for pancreas- and CNS-specific gene deletion.","date":"2013","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/23996959","citation_count":20,"is_preprint":false},{"pmid":"26492922","id":"PMC_26492922","title":"Nkx2.2 is expressed in a subset of enteroendocrine cells with expanded lineage potential.","date":"2015","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26492922","citation_count":19,"is_preprint":false},{"pmid":"14504237","id":"PMC_14504237","title":"Undulated short-tail deletion mutation in the mouse ablates Pax1 and leads to ectopic activation of neighboring Nkx2-2 in domains that normally express Pax1.","date":"2003","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14504237","citation_count":18,"is_preprint":false},{"pmid":"10772886","id":"PMC_10772886","title":"The homeodomain of Nkx2.2 carries two cooperatively acting nuclear localization signals.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10772886","citation_count":17,"is_preprint":false},{"pmid":"30680064","id":"PMC_30680064","title":"NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30680064","citation_count":16,"is_preprint":false},{"pmid":"30210629","id":"PMC_30210629","title":"NKX2-2 Suppresses Osteosarcoma Metastasis and Proliferation by Downregulating Multiple Target Genes.","date":"2018","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30210629","citation_count":15,"is_preprint":false},{"pmid":"22539496","id":"PMC_22539496","title":"Generation of Nkx2.2:lacZ mice using recombination-mediated cassette exchange technology.","date":"2012","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/22539496","citation_count":15,"is_preprint":false},{"pmid":"25919494","id":"PMC_25919494","title":"Nkx2.2 and Nkx2.9 are the key regulators to determine cell fate of branchial and visceral motor neurons in caudal hindbrain.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25919494","citation_count":15,"is_preprint":false},{"pmid":"19965928","id":"PMC_19965928","title":"Nkx2.2 activates the ghrelin promoter in pancreatic islet cells.","date":"2009","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19965928","citation_count":15,"is_preprint":false},{"pmid":"25699080","id":"PMC_25699080","title":"Regulation of the Human Ghrelin Promoter Activity by Transcription Factors, NF-κB and Nkx2.2.","date":"2015","source":"International journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25699080","citation_count":14,"is_preprint":false},{"pmid":"32818257","id":"PMC_32818257","title":"NKX2-2 Mutation Causes Congenital Diabetes and Infantile Obesity With Paradoxical Glucose-Induced Ghrelin Secretion.","date":"2020","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32818257","citation_count":13,"is_preprint":false},{"pmid":"24401371","id":"PMC_24401371","title":"Nato3 plays an integral role in dorsoventral patterning of the spinal cord by segregating floor plate/p3 fates via Nkx2.2 suppression and Foxa2 maintenance.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24401371","citation_count":13,"is_preprint":false},{"pmid":"19258013","id":"PMC_19258013","title":"Spatially distinct functions of PAX6 and NKX2.2 during gliogenesis in the ventral spinal cord.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19258013","citation_count":12,"is_preprint":false},{"pmid":"37364986","id":"PMC_37364986","title":"Major β cell-specific functions of NKX2.2 are mediated via the NK2-specific domain.","date":"2023","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/37364986","citation_count":11,"is_preprint":false},{"pmid":"35815619","id":"PMC_35815619","title":"Gata2, Nkx2-2 and Skor2 form a transcription factor network regulating development of a midbrain GABAergic neuron subtype with characteristics of REM-sleep regulatory neurons.","date":"2022","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35815619","citation_count":11,"is_preprint":false},{"pmid":"24821492","id":"PMC_24821492","title":"Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2.","date":"2014","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24821492","citation_count":11,"is_preprint":false},{"pmid":"17600517","id":"PMC_17600517","title":"Nkx2.2 expression in differentiation of oligodendrocyte precursor cells and inhibitory factors for differentiation of oligodendrocytes after traumatic spinal cord injury.","date":"2007","source":"Journal of neurotrauma","url":"https://pubmed.ncbi.nlm.nih.gov/17600517","citation_count":11,"is_preprint":false},{"pmid":"34097879","id":"PMC_34097879","title":"Nkx2-2 expressing taste cells in endoderm-derived taste papillae are committed to the type III lineage.","date":"2021","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34097879","citation_count":10,"is_preprint":false},{"pmid":"20951692","id":"PMC_20951692","title":"Genetically-defined lineage tracing of Nkx2.2-expressing cells in chick spinal cord.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20951692","citation_count":10,"is_preprint":false},{"pmid":"21352540","id":"PMC_21352540","title":"Novel computational analysis of protein binding array data identifies direct targets of Nkx2.2 in the pancreas.","date":"2011","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21352540","citation_count":9,"is_preprint":false},{"pmid":"22433950","id":"PMC_22433950","title":"Ectopic transgenic expression of NKX2.2 induces differentiation of adult pancreatic progenitors and mediates islet regeneration.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22433950","citation_count":8,"is_preprint":false},{"pmid":"25840610","id":"PMC_25840610","title":"Generation of a Nkx2.2(Cre) knock-in mouse line: Analysis of cell lineages in the central nervous system.","date":"2015","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/25840610","citation_count":7,"is_preprint":false},{"pmid":"25948942","id":"PMC_25948942","title":"Upregulation of NKX2.2, a target of EWSR1/FLI1 fusion transcript, in primary renal Ewing sarcoma.","date":"2015","source":"Journal of cytology","url":"https://pubmed.ncbi.nlm.nih.gov/25948942","citation_count":7,"is_preprint":false},{"pmid":"29295693","id":"PMC_29295693","title":"Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development.","date":"2020","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/29295693","citation_count":6,"is_preprint":false},{"pmid":"38546197","id":"PMC_38546197","title":"The myelination-associated G protein-coupled receptor 37 is regulated by Zfp488, Nkx2.2, and Sox10 during oligodendrocyte differentiation.","date":"2024","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/38546197","citation_count":6,"is_preprint":false},{"pmid":"34584801","id":"PMC_34584801","title":"Ewing Sarcoma and Ewing-Like Sarcoma and the Role of NKX2.2 Immunoreactivity.","date":"2021","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/34584801","citation_count":6,"is_preprint":false},{"pmid":"20599218","id":"PMC_20599218","title":"Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site.","date":"2010","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/20599218","citation_count":6,"is_preprint":false},{"pmid":"38234938","id":"PMC_38234938","title":"Expression of NKX2.2 in Non-Ewing Tumors With Round Cell Morphology.","date":"2023","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/38234938","citation_count":5,"is_preprint":false},{"pmid":"39797760","id":"PMC_39797760","title":"NKX2.2 and KLF4 cooperate to regulate α-cell identity.","date":"2025","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/39797760","citation_count":5,"is_preprint":false},{"pmid":"32716131","id":"PMC_32716131","title":"Rapid induction of gliogenesis in OLIG2 and NKX2.2-expressing progenitors-derived spheroids.","date":"2020","source":"Stem cells translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32716131","citation_count":5,"is_preprint":false},{"pmid":"27956177","id":"PMC_27956177","title":"Nuclear import of Nkx2-2 is mediated by multiple pathways.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27956177","citation_count":5,"is_preprint":false},{"pmid":"38689254","id":"PMC_38689254","title":"NKX2-2 based nuclei sorting on frozen human archival pancreas enables the enrichment of islet endocrine populations for single-nucleus RNA sequencing.","date":"2024","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38689254","citation_count":4,"is_preprint":false},{"pmid":"36656211","id":"PMC_36656211","title":"Correlation NKX2.2 IHC and EWSR1 break-apart FISH in the diagnosis of Ewing sarcoma: Can combined NKX2.2 and CD99 immunoexpression obviate or minimize the need of FISH testing? First assessment study from Indian tertiary cancer care center.","date":"2023","source":"Indian journal of pathology & microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36656211","citation_count":4,"is_preprint":false},{"pmid":"23284718","id":"PMC_23284718","title":"Nkx2.2+ progenitors generate somatic motoneurons in the chick spinal cord.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23284718","citation_count":4,"is_preprint":false},{"pmid":"37399332","id":"PMC_37399332","title":"Differential use of the Nkx2.2 NK2 domain in developing pancreatic islets and neurons.","date":"2023","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/37399332","citation_count":3,"is_preprint":false},{"pmid":"37191854","id":"PMC_37191854","title":"Role of Gltp in Maturation of Oligodendrocytes Under the Regulation of Nkx2.2.","date":"2023","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/37191854","citation_count":3,"is_preprint":false},{"pmid":"39460795","id":"PMC_39460795","title":"Differential regulation of Shh-Gli1 cell signalling pathway on homeodomain transcription factors Nkx2.2 and Pax6 during the medulloblastoma genesis.","date":"2024","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/39460795","citation_count":3,"is_preprint":false},{"pmid":"36999306","id":"PMC_36999306","title":"CD99 and NKX2.2 positive neuroblastoma diagnosed on cytology: A potential diagnostic pitfall and necessity of pathological evaluation of the primary site.","date":"2023","source":"Diagnostic cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/36999306","citation_count":3,"is_preprint":false},{"pmid":"35236160","id":"PMC_35236160","title":"The Roles of Different Multigene Combinations of Pdx1, Ngn3, Sox9, Pax4, and Nkx2.2 in the Reprogramming of Canine ADSCs Into IPCs.","date":"2022","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/35236160","citation_count":3,"is_preprint":false},{"pmid":"38649148","id":"PMC_38649148","title":"Clinicopathologic Correlates of PIT1 and SF1-Multilineage Pituitary Neuroendocrine Tumors and the Diagnostic Utility of NKX2.2 Immunohistochemistry in Pituitary Pathology.","date":"2025","source":"Archives of pathology & laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38649148","citation_count":3,"is_preprint":false},{"pmid":"35152629","id":"PMC_35152629","title":"[Expression and diagnostic value of NKX3.1 and NKX2.2 in mesenchymal chondrosarcoma].","date":"2022","source":"Zhonghua bing li xue za zhi = Chinese journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35152629","citation_count":1,"is_preprint":false},{"pmid":"36737643","id":"PMC_36737643","title":"Enrichment of human embryonic stem cell-derived V3 interneurons using an Nkx2-2 gene-specific reporter.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36737643","citation_count":1,"is_preprint":false},{"pmid":"37821536","id":"PMC_37821536","title":"A novel stop-loss mutation in NKX2-2 gene as a cause of neonatal diabetes mellitus: molecular characterization and structural analysis.","date":"2023","source":"Acta diabetologica","url":"https://pubmed.ncbi.nlm.nih.gov/37821536","citation_count":1,"is_preprint":false},{"pmid":"40667117","id":"PMC_40667117","title":"CHD4 and NKX2.2 Cooperate to Regulate Beta Cell Function by Repressing Non-Beta Cell Gene Programs.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40667117","citation_count":1,"is_preprint":false},{"pmid":"38223000","id":"PMC_38223000","title":"Homeodomain Transcription Factors Nkx2.2 and Pax6 as Novel Biomarkers for Meningioma Tumor Treatment.","date":"2022","source":"Indian journal of clinical biochemistry : IJCB","url":"https://pubmed.ncbi.nlm.nih.gov/38223000","citation_count":0,"is_preprint":false},{"pmid":"39415990","id":"PMC_39415990","title":"Independent control of neurogenesis and dorsoventral patterning by NKX2-2.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39415990","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51880,"output_tokens":9829,"usd":0.151537,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19981,"output_tokens":5891,"usd":0.12359,"stage2_stop_reason":"end_turn"},"total_usd":0.275127,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Nkx2.2 is required downstream of graded Sonic hedgehog signaling to specify ventral neuronal identity in the neural tube; in Nkx2.2 mutant mice, progenitor cells that normally form V3 interneurons instead generate motor neurons, while Pax6 expression remains unchanged, placing Nkx2.2 as a primary interpreter of graded Shh signals rather than an indirect effector of Pax6.\",\n      \"method\": \"Loss-of-function mouse genetics (Nkx2.2 null mutants), immunohistochemistry, epistasis analysis with Pax6 mutants\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, epistasis with Pax6 mutants, replicated in multiple analyses\",\n      \"pmids\": [\"10217145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Nkx2.2 is required for the final differentiation of pancreatic beta cells; mice lacking Nkx2.2 completely lack insulin-producing beta cells and have reduced alpha and PP cells, with remaining islet cells expressing some but not all beta cell markers (e.g., IAPP and Pdx1 present, but Glut2 and Nkx6.1 absent), indicating beta cells are arrested in an incompletely differentiated state.\",\n      \"method\": \"Null mouse genetics, immunohistochemistry, marker expression analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple orthogonal marker analyses, widely replicated\",\n      \"pmids\": [\"9584121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Co-expression of Nkx2.2 and Olig2 in the spinal cord promotes ectopic and precocious oligodendrocyte differentiation; both proteins function as transcriptional repressors in this assay, and forced Neurogenin1 expression blocks this cooperative effect.\",\n      \"method\": \"Ectopic expression in chick spinal cord (electroporation), reporter assays, epistasis with Neurogenin1\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo gain-of-function with defined phenotype, functional epistasis, replicated across multiple studies\",\n      \"pmids\": [\"11567617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell differentiation; Nkx6.1/Nkx2.2 double mutant islet development is identical to Nkx2.2 single mutant development (beta-cell precursors survive but fail to differentiate), establishing Nkx6.1 downstream of Nkx2.2.\",\n      \"method\": \"Double-mutant mouse genetics, epistasis analysis, immunohistochemistry\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double-mutant rescue logic, clean KO phenotype\",\n      \"pmids\": [\"11076772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Nkx2.2 regulates the differentiation and maturation (but not initial specification) of oligodendrocyte progenitors in the rodent CNS; Nkx2.2-null mutants show dramatically retarded MBP+ and PLP-DM20+ oligodendrocyte differentiation along the entire rostrocaudal axis, while astrocytic differentiation is unaffected. Additionally, absence of Nkx2.2 causes ventral expansion of Olig1/Olig2 expression.\",\n      \"method\": \"Loss-of-function mouse genetics (Nkx2.2 null), immunohistochemistry, overexpression in fibroblasts (PLP promoter reporter)\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, gain-of-function corroboration, multiple markers\",\n      \"pmids\": [\"11526078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NKX2.2 is a transcriptional target of the EWS/FLI fusion protein in Ewing's sarcoma and is necessary for the oncogenic transformation phenotype; knockdown of NKX2.2 by RNAi in Ewing's sarcoma cells abrogates tumorigenic properties.\",\n      \"method\": \"Retroviral RNAi knockdown, reexpression rescue, microarray expression profiling\",\n      \"journal\": \"Cancer Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function with defined oncogenic phenotype, rescue experiment, combined with genome-wide expression profiling\",\n      \"pmids\": [\"16697960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NKX2.2 mediates oncogenic transformation in Ewing's sarcoma solely through transcriptional repression: its DNA-binding and repressor domains are required for oncogenesis while its transcriptional activation domain is dispensable. NKX2.2 recruits TLE (Groucho) and HDAC co-repressors, and blockade of TLE or HDAC function inhibits the transformed phenotype. ChIP-chip shows NKX2.2 directly binds and represses target genes.\",\n      \"method\": \"Structure-function mutagenesis, microarray, ChIP-chip, pharmacological inhibition of TLE/HDAC, RNAi\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — structure-function mutagenesis combined with ChIP-chip and pharmacological rescue, multiple orthogonal methods in one study\",\n      \"pmids\": [\"18414662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nkx2.2 is part of a large repression complex in pancreatic beta cells that includes DNMT3a, Grg3, and HDAC1. The TN (tinman) domain of Nkx2.2 is required for interaction with Grg3; mutation of the TN domain abolishes Grg3 interaction, disrupts beta-cell specification, and causes ectopic Arx expression leading to beta-to-alpha cell transdifferentiation. Nkx2.2 preferentially recruits Grg3 and HDAC1 to the methylated Arx promoter in beta cells. Subsequent removal of Arx in TN-mutant mice reverts the beta-to-alpha cell conversion.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, endogenous TN-domain point mutation knock-in mice, DNMT3a beta-cell-specific KO, Arx conditional deletion rescue\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — co-IP, ChIP, multiple knock-in/KO models with rescue, multiple orthogonal methods in one study\",\n      \"pmids\": [\"22056672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Nkx2.2 directly binds to the Pdgfra promoter and represses its expression, thereby acting as a timing switch for oligodendrocyte differentiation. Induced Nkx2.2 expression in early OPCs causes precocious oligodendrocyte differentiation; conditional ablation delays maturation. Genetic ablation of Pdgfra mimics Nkx2.2 overexpression in accelerating OPC differentiation.\",\n      \"method\": \"ChIP, conditional KO, gain-of-function overexpression in OPCs, genetic epistasis with Pdgfra KO\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct promoter binding by ChIP, conditional KO and OE with phenotype, genetic epistasis\",\n      \"pmids\": [\"24449836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Nkx2.2 forms a physical protein complex with Olig2 in mammalian cells and in yeast two-hybrid assay; this interaction is specific (Olig2 does not bind Nkx6.1; Nkx2.2 does not bind NeuroD). Deletion mapping showed the physical complex is insufficient for oligodendrocyte progenitor induction but may mediate the cross-repressive interaction establishing the pMN-p3 boundary.\",\n      \"method\": \"Co-immunoprecipitation in mammalian cells, yeast two-hybrid, deletion mapping\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal protein interaction assays (mammalian Co-IP + yeast two-hybrid), single lab, interaction shown but functional sufficiency was negative\",\n      \"pmids\": [\"14573534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Lmx1b and Pet-1 act downstream of Nkx2.2 in specifying the serotonergic (5-HT) neurotransmitter phenotype; combined ectopic expression of Lmx1b, Pet-1, and Nkx2.2 drives 5-HT differentiation in the dorsal spinal cord where Nkx2.2 is normally expressed, establishing a molecular pathway sufficient to specify serotonergic identity.\",\n      \"method\": \"Loss-of-function mouse genetics (Lmx1b null, Nkx2.2 null), ectopic expression in chick spinal cord, epistasis analysis\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis, in vivo gain-of-function sufficient to specify cell fate, multiple KO models\",\n      \"pmids\": [\"14602809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Pax4 genetically interacts with Nkx2.2 to initiate pancreatic beta-cell differentiation; loss of Pax4 prevents expression of Pdx1, HB9, and insulin in beta-cell precursors, and this role is accomplished via genetic interaction with Nkx2.2.\",\n      \"method\": \"Loss-of-function mouse genetics (Pax4 KO), immunohistochemistry, epistasis analysis with Nkx2.2\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis, single lab, KO phenotype with marker analysis\",\n      \"pmids\": [\"14729487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Nkx2.2 represses myelin basic protein (MBP) gene expression in oligodendrocyte progenitors by binding two regulatory elements in the MBP promoter, blocking Puralpha binding, and recruiting an HDAC1-mSin3A co-repressor complex; the transcription factor Sp1 competes off Nkx2.2 from its binding site and reverses this repression.\",\n      \"method\": \"In vitro DNA binding assay (EMSA), reporter assays, co-immunoprecipitation, chromatin immunoprecipitation\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro binding, ChIP, co-IP identifying corepressor complex, multiple orthogonal methods in one study\",\n      \"pmids\": [\"15695521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nkx2.2 directly occupies the insulin gene control region in intact beta cells and also occupies the IAPP, pax-4, and glucokinase control sequences in vivo. In vitro DNA-binding and transient transfection assays confirmed Nkx2.2 binding and its effect on insulin gene expression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) in beta cells, EMSA, transient transfection reporter assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP demonstrating in vivo occupancy, EMSA for direct binding, reporter assays in same study\",\n      \"pmids\": [\"12426319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PDX-1, FoxA2, and Nkx2.2 directly bind to the conserved region 3 (bp -8118 to -7750) of the mafA promoter in vivo, and Nkx2.2 mediates activation of this region; MafA expression is undetected in Nkx2.2-null pancreas.\",\n      \"method\": \"ChIP, reporter assays with mutational analysis, siRNA knockdown, Nkx2.2 null mouse analysis\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP for in vivo binding, mutational analysis, KO confirmation, multiple orthogonal methods\",\n      \"pmids\": [\"16847327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nkx2.2-repressor activity (Nkx2.2-Engrailed repressor derivative) is sufficient to fully rescue glucagon-producing alpha-cells and partially rescue insulin-producing beta-cells in Nkx2.2-null mice. Insulin-positive rescued cells lack mature beta-cell markers MafA and Glut2, indicating additional activator functions are required for maturation. Grg3 is highly expressed in embryonic pancreas and physically interacts with Nkx2.2 through its TN domain.\",\n      \"method\": \"Transgenic dominant-derivative mouse lines, immunohistochemistry, co-immunoprecipitation\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic rescue experiment with defined functional readout plus co-IP of TN-Grg3 interaction\",\n      \"pmids\": [\"17202186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nkx2.2 is required for maintenance and function of the mature beta cell; expressing a repressor derivative of Nkx2.2 in mature beta cells disrupts endogenous Nkx2.2 and causes downregulation of MafA and Glut2, reduced insulin gene expression and pancreatic insulin content, impaired insulin secretion, and glucose intolerance.\",\n      \"method\": \"Transgenic mice expressing Nkx2.2-repressor derivative in mature beta cells, glucose tolerance tests, insulin secretion assays, marker expression analysis\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic dominant-negative approach, multiple functional readouts, single lab\",\n      \"pmids\": [\"17456846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nkx2.2 regulates cell fate choices within the intestinal enteroendocrine population; Nkx2.2-null mice lack or have reduced several hormone-producing enteroendocrine cell populations with a corresponding increase in ghrelin cells, and Nkx2.2 appears to function upstream of Pax6 in intestinal cell fate (Pax6 expression is decreased in Nkx2.2-null intestine).\",\n      \"method\": \"Nkx2.2 null mouse genetics, immunohistochemistry, marker expression analysis, epistasis with Pax6\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined lineage phenotype, pathway placement via epistasis, single lab\",\n      \"pmids\": [\"18022152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nkx2.2 cooperatively activates NeuroD1 transcription with Ngn3 in endocrine progenitor cells and maintains NeuroD1 expression in mature beta cells. Nkx2.2 regulates NeuroD1 through two independent promoter elements: one directly bound and activated by Nkx2.2, and one regulated indirectly. Nkx2.2 activity is required to facilitate Ngn3-mediated NeuroD1 activation.\",\n      \"method\": \"Reporter assays, ChIP, Nkx2.2 KO mouse analysis, zebrafish knockdown, promoter deletion analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct promoter binding by ChIP, multiple KO/KD models, reporter assays with two species validation\",\n      \"pmids\": [\"19759004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nkx2.2 can bind to and activate the ghrelin promoter; the region -619 to -488 bp upstream of the translational start site is necessary for repression of ghrelin in alphaTC1 and betaTC6 cells. Upregulation of ghrelin in Nkx2.2-null mice is not due to loss of ghrelin promoter repression in non-ghrelin islet cells.\",\n      \"method\": \"Reporter assays, ChIP, EMSA, Nkx2.2 null mouse analysis\",\n      \"journal\": \"Molecular Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct binding by EMSA and ChIP, reporter assay, KO validation, single lab\",\n      \"pmids\": [\"19965928\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nkx2.2 transcription factor binds to the Sirt2 promoter via HDAC-1 in oligodendroglial precursor cells and negatively regulates Sirt2 expression. HDAC-1 knockdown attenuates Nkx2.2 binding capacity and releases Sirt2 repression. Nkx2.2 overexpression down-regulates Sirt2 and delays CG4 cell differentiation.\",\n      \"method\": \"ChIP, HDAC-1 RNAi, Nkx2.2 overexpression in CG4 oligodendroglial precursor cells\",\n      \"journal\": \"Journal of Molecular Cell Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct binding, RNAi functional validation, single lab\",\n      \"pmids\": [\"21669943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The homeodomain of Nkx2.2 contains two cooperatively acting monopartite nuclear localization signals (NLS): proximal NLS (KKRKRR) at the N-terminus of the homeodomain and distal NLS (RYKMKRAR) at its C-terminus. Each NLS alone is sufficient but inefficient for nuclear transport; both act cooperatively for complete nuclear import.\",\n      \"method\": \"Deletion mutant analysis, nuclear localization assays\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deletion mutagenesis with functional localization readout, single lab\",\n      \"pmids\": [\"10772886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nuclear import of Nkx2-2 is mediated by multiple pathways: importin α1 interacts with Nkx2-2 and transports it together with importin β1 in vitro; importin β1 and importin 13 also directly interact with Nkx2-2 and transport it in vitro. Mutation of NLS1 or NLS2 has no effect on interaction with importin α1 or importin 13, but significantly reduces binding to importin β1.\",\n      \"method\": \"GST pulldown, in vitro nuclear import assay, importin β1 RNAi, Bimax2 overexpression, NLS mutagenesis\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple in vitro interaction and import assays, mutagenesis, single lab\",\n      \"pmids\": [\"27956177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Nkx2.2 acts downstream of Neurog3 in the endocrine progenitor lineage for beta cell differentiation; conditional ablation of Nkx2.2 specifically in Neurog3+ progenitors recapitulates the Nkx2.2 null beta cell phenotype despite maintenance of many beta cell transcriptional network components, demonstrating Nkx2.2 has essential activities within the endocrine progenitor population beyond its earlier pancreatic progenitor role.\",\n      \"method\": \"Conditional KO using Neurog3-Cre, comparison with germline Nkx2.2 null, gene expression analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with stage-specific phenotype, rigorous comparison with germline KO, multiple markers\",\n      \"pmids\": [\"28071588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In mice lacking both Nkx2.2 and Nkx2.9, the presumptive p3 domain progenitors convert to motor neurons and never acquire V3 interneuron fate, demonstrating that Nkx2 transcription factors repress the motor neuron lineage program (including Olig2) to establish V3 progenitor cells. Additionally, combined loss of Nkx2.2 and Nkx2.9 results in a smaller and functionally impaired floor plate causing severe commissural axon pathfinding defects.\",\n      \"method\": \"Double-mutant mouse genetics, lineage analysis, electrophysiology, immunohistochemistry\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-mutant epistasis, multiple cellular phenotypes, functional electrophysiology readout\",\n      \"pmids\": [\"21068056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NKX2-2 regulates oligodendrocyte differentiation through domain-specific interactions with distinct transcriptional corepressors: the N-terminal Tinman (TN) domain recruits GRG3, and the C-terminal domain recruits HDAC1 and DNMT3A. Both domains synergistically promote OL differentiation in vivo. The NK2-specific domain suppresses the function of the C-terminal domain in OL differentiation.\",\n      \"method\": \"Coimmunoprecipitation, in ovo electroporation in chick spinal cord, immunofluorescence, domain deletion analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — co-IP identifying cofactors, in vivo gain-of-function with domain mutants, multiple orthogonal methods\",\n      \"pmids\": [\"31932307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nkx2.2 and Arx genetically interact in pancreatic endocrine progenitors; in the Nkx2.2-null context, Arx is necessary for upregulation of ghrelin mRNA in epsilon cells but not for the expansion of the ghrelin cell population. In the absence of Arx, Nkx2.2 becomes essential for repression of somatostatin gene expression, and Arx is required in Neurog3+ endocrine progenitors.\",\n      \"method\": \"Compound conditional KO mouse genetics (Nkx2.2 null; Arx conditional deletion), immunohistochemistry, gene expression analysis\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — compound genetic analysis establishing interaction, defined cellular phenotypes, single lab\",\n      \"pmids\": [\"21856296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Ceramide galactosyltransferase (CGT) expression in oligodendrocytes is positively regulated by Nkx2.2 at the promoter level; Nkx2.2 strongly activates the CGT promoter in reporter assays, and this activation is cancelled by co-expression of OLIG2, which binds a repressive element in the first intron of CGT.\",\n      \"method\": \"Reporter assay (luciferase), transcription factor co-expression in oligodendroglioma cells, identification of binding element\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — reporter assay only, single lab, no direct binding confirmed for NKX2.2 to CGT in this study\",\n      \"pmids\": [\"24821492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nkx2.2 regulates enteroendocrine cell specification at multiple stages in the intestine; serotonin-producing enterochromaffin cells are most severely reduced in all Nkx2.2 mutant conditions. The transcription factor Lmx1a is expressed in enterochromaffin cells downstream of Nkx2.2, and Lmx1a-deficient mice have reduced expression of Tph1, the rate-limiting enzyme for serotonin biosynthesis.\",\n      \"method\": \"Stage- and cell type-specific Nkx2.2 conditional KO, lineage tracing, Lmx1a KO mouse analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple conditional KO models, genetic epistasis establishing Lmx1a downstream of Nkx2.2, defined lineage phenotype\",\n      \"pmids\": [\"27287799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The NK2-specific domain (SD) of NKX2.2 is required for beta cell-specific functions: SD mutation in mice prevents developmental progression of beta cell precursors into mature insulin-expressing beta cells, causing neonatal diabetes, and impairs a subset of adult beta cell gene expression programs. However, the SD is entirely dispensable for NKX2.2-dependent CNS cell type development, demonstrating tissue-specific domain requirement. SD-dependent interactions occur with components of chromatin remodelers and the nuclear pore complex.\",\n      \"method\": \"Endogenous SD point-mutation knock-in mice, gene expression analysis, co-immunoprecipitation for chromatin remodeler interactions\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — endogenous domain mutation with tissue-specific phenotype, multiple functional readouts, interaction data\",\n      \"pmids\": [\"37364986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NKX2.2 is critical for pancreatic alpha cell identity by directly activating alpha-cell genes and repressing alternate islet cell fate genes. KLF4 is enriched in alpha cells, co-occupies NKX2.2-bound alpha-cell promoters, is necessary for NKX2.2 promoter occupancy in alpha cells, and co-regulates NKX2.2 alpha-cell transcriptional targets. Overexpression of Klf4 in beta cells is sufficient to manipulate chromatin accessibility and increase NKX2.2 binding at alpha-cell-specific promoter sites.\",\n      \"method\": \"ChIP-seq, ATAC-seq, conditional KO (Nkx2.2 and Klf4), Klf4 overexpression in beta cells, gene expression analysis\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP-seq for direct binding, ATAC-seq for chromatin remodeling, KO and OE experiments with defined phenotypes, single recent lab\",\n      \"pmids\": [\"39797760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CHD4 (chromodomain helicase DNA-binding protein 4) is an NKX2.2 interacting partner in beta cells identified by proteomics; CHD4 and NKX2.2 cooperatively bind to and repress non-beta cell genes, including Kcnj5 (encoding GIRK4 potassium channel). Deletion of Chd4 in beta cells causes diabetes with disrupted islet integrity, impaired calcium signaling, and downregulation of beta cell regulatory genes; aberrant GIRK4 expression causes impaired glucose-stimulated insulin secretion.\",\n      \"method\": \"Unbiased proteomics screen, co-immunoprecipitation, Chd4 conditional KO (beta-cell specific), ChIP, calcium imaging, glucose-stimulated insulin secretion assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics + co-IP identification, conditional KO with functional readout, ChIP for co-occupancy; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"40667117\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NKX2-2 represses proneural gene NEUROG2 by two distinct mechanisms in rodent versus human spinal progenitors: in rodents, NKX2-2 represses Olig2 and the motor neuron lineage through its tinman domain (leading to loss of Neurog2); in human vpMN progenitors, NKX2-2 represses NEUROG2 but not OLIG2, allowing motor neurogenesis to proceed in a delayed manner. Ectopic expression of tinman-mutant Nkx2-2 in mouse pMNs phenocopies human vpMNs.\",\n      \"method\": \"In vivo and in vitro gain/loss-of-function, ectopic expression of tinman domain mutants in mouse, comparative human vs rodent neural progenitor analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-specific mutant with in vivo phenotype, comparative species analysis; preprint, not peer-reviewed\",\n      \"pmids\": [\"39415990\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In Ewing's sarcoma, NKX2-2 represses cell adhesion and extracellular matrix organization genes; NKX2-2-depleted cells form more focal adhesions, organized actin stress fibers, spread over wider area, and display increased migration and substrate adhesion. NKX2-2 specifically represses the actin-stabilizing protein zyxin.\",\n      \"method\": \"RNA-seq after NKX2-2 knockdown, cell adhesion/migration assays, immunofluorescence for actin and focal adhesions\",\n      \"journal\": \"Genes & Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transcriptome-wide RNAseq, cellular functional assays, single lab\",\n      \"pmids\": [\"26000096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NKX2.2 overexpression in glioblastoma-derived glioma-initiating cells (GICs) induces oligodendroglial differentiation and suppresses self-renewal capacity; conversely, Nkx2.2 downregulation in mouse neural progenitor cells accelerates GBM formation. Downregulation of NKX2.2 correlates with increased tumor malignancy in both mouse models and human specimens.\",\n      \"method\": \"Overexpression in GICs, loss-of-function in mouse NPCs (in vivo), neurosphere self-renewal assays, differentiation marker analysis\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain and loss-of-function with defined cellular phenotype, in vivo confirmation, single lab\",\n      \"pmids\": [\"21169405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Nkx2.2 and Zfp488 act as transcriptional activators (in addition to their known repressor roles) for the G protein-coupled receptor Gpr37 in differentiating oligodendrocytes; both transcription factors bind a regulatory region downstream of the Gpr37 gene in vivo and cooperate with Sox10 to activate Gpr37 expression, which modulates myelination.\",\n      \"method\": \"Overexpression in CG4 cells, Nkx2.2-deficient mouse analysis, ChIP for in vivo binding, reporter assays\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo ChIP, KO mouse validation, reporter assays, single lab\",\n      \"pmids\": [\"38546197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Nkx2-2-expressing taste cells in endoderm-derived circumvallate and foliate papillae are committed to the type III taste cell lineage; Nkx2-2 knockout neonatal mice do not express key type III taste cell marker genes, while type I and II marker genes are unaffected. Lineage tracing showed Nkx2-2+ cells differentiate into type III but not type II or I cells in posterior taste papillae.\",\n      \"method\": \"Conditional lineage tracing (Nkx2-2-Cre), Nkx2-2 KO mouse analysis, single-cell RNA-seq, in situ hybridization, immunostaining\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — lineage tracing plus KO with defined cell-type-specific phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"34097879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Nkx2.2-expressing perineurial glia in mice are CNS-derived and essential for motor nerve development and Schwann cell differentiation; in mice lacking Nkx2.2, motor nerve development is impaired.\",\n      \"method\": \"Nkx2.2:EGFP transgenic reporter, Nkx2.2 null mouse analysis, RNA expression analysis, antibody labeling\",\n      \"journal\": \"Developmental Dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined cellular phenotype, transgenic reporter line to trace cell origin, single lab\",\n      \"pmids\": [\"24979729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A frameshift mutation (c.772delC, p.Q258SFs*59) in the NKX2-2 homeodomain results in an elongated protein that lacks normal DNA binding activity and transcriptional function, establishing that DNA binding by NKX2-2 is required for its normal transcription factor activity. Structural analysis indicated alterations in tertiary structure contributing to dysfunction.\",\n      \"method\": \"Functional transactivation assay, DNA binding assay, nuclear localization assay, protein structural modeling of mutant\",\n      \"journal\": \"Acta Diabetologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Weak — direct functional assays on disease-causing mutation, single case/lab, no independent replication\",\n      \"pmids\": [\"37821536\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NKX2-2 is a homeodomain transcription factor that functions primarily as a transcriptional repressor (recruiting corepressor complexes including Grg3/TLE, HDAC1, and DNMT3A via its TN and C-terminal domains) but also as a context-dependent activator, acting downstream of Sonic hedgehog signaling to specify distinct progenitor cell identities in the ventral neural tube, pancreatic islet (beta, alpha, and epsilon cells), intestinal enteroendocrine cells, and oligodendrocytes; its beta cell-specific functions are mediated through the NK2-specific domain which interacts with chromatin remodelers, while its CNS functions are largely domain-independent, and in Ewing's sarcoma it acts as an obligatory downstream effector of EWS/FLI that drives oncogenesis through transcriptional repression of differentiation and mesenchymal genes.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NKX2-2 is a homeodomain transcription factor that interprets graded developmental signals to specify cell identity in multiple lineages, acting predominantly as a transcriptional repressor but also as a context-dependent activator [#0, #6, #18]. In the ventral neural tube it functions downstream of Sonic hedgehog to specify V3 interneuron fate, and together with the paralog Nkx2.9 it represses the motor neuron program (including Olig2) to establish the p3 progenitor domain [#0, #24]; it likewise controls the timing of oligodendrocyte differentiation and maturation, in part by directly binding and repressing the Pdgfra promoter [#4, #8]. In the pancreatic islet, NKX2-2 is required for terminal differentiation and maintenance of insulin-producing beta cells and for alpha- and epsilon-cell identity, operating downstream of Neurog3 in the endocrine progenitor lineage and upstream of Nkx6.1 [#1, #3, #23, #30]. It directly occupies the insulin, IAPP, glucokinase, mafA, and NeuroD1 control regions, activating beta-cell maturation genes while repressing alternate-fate genes such as Arx and ghrelin [#13, #14, #18, #7]. Repressive function is executed by recruiting corepressor complexes: the N-terminal TN (tinman) domain binds Grg3/TLE, while a C-terminal region recruits HDAC1 and DNMT3A, directing repression of methylated targets such as the Arx promoter to prevent beta-to-alpha transdifferentiation [#7, #25]. The NK2-specific domain confers beta-cell-specific functions through interactions with chromatin remodelers and the nuclear pore complex but is dispensable for CNS roles, defining tissue-specific domain requirements [#29]. NKX2-2 also directs intestinal enteroendocrine cell fate and type III taste cell commitment [#28, #36]. In Ewing's sarcoma, NKX2-2 is an obligatory transcriptional target and downstream effector of the EWS/FLI fusion that drives oncogenesis solely through its repressor activity, silencing differentiation, cell adhesion, and extracellular matrix genes [#5, #6, #33]. A frameshift mutation in the NKX2-2 homeodomain that abolishes DNA binding causes neonatal diabetes [#38].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that NKX2-2 is required for terminal differentiation of insulin-producing beta cells, defining its first developmental requirement.\",\n      \"evidence\": \"Null mouse genetics with islet marker analysis\",\n      \"pmids\": [\"9584121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify direct target genes\", \"Mechanism of arrest (repressor vs activator) not resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed NKX2-2 is a primary interpreter of graded Shh signaling in the neural tube, converting a signaling gradient into V3 interneuron identity rather than acting through Pax6.\",\n      \"evidence\": \"Nkx2.2 null mice, immunohistochemistry, epistasis with Pax6 mutants\",\n      \"pmids\": [\"10217145\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets in neural tube not defined\", \"Did not address downstream effector genes\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined the nuclear import determinants of NKX2-2, mapping two cooperative NLS within the homeodomain.\",\n      \"evidence\": \"Deletion mutant analysis and nuclear localization assays\",\n      \"pmids\": [\"10772886\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Import receptors not identified at this stage\", \"Single-lab functional readout\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Placed Nkx6.1 genetically downstream of NKX2-2 in beta-cell differentiation, ordering the islet transcription factor hierarchy.\",\n      \"evidence\": \"Double-mutant mouse epistasis\",\n      \"pmids\": [\"11076772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of Nkx6.1 unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrated NKX2-2 cooperates with Olig2 as a repressor to drive oligodendrocyte differentiation and that it controls OL maturation in vivo.\",\n      \"evidence\": \"Ectopic expression in chick spinal cord, null mouse genetics, reporter assays\",\n      \"pmids\": [\"11567617\", \"11526078\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct OL target genes not yet identified\", \"Nature of the Olig2 interaction unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed NKX2-2 physically complexes with Olig2 and placed it upstream of serotonergic specification factors, linking protein interaction to lineage cross-repression.\",\n      \"evidence\": \"Co-IP, yeast two-hybrid, deletion mapping; ectopic expression with Lmx1b/Pet-1 in chick\",\n      \"pmids\": [\"14573534\", \"14602809\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Olig2 complex shown insufficient for OPC induction\", \"Functional relevance of physical interaction not established\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified direct NKX2-2 occupancy at islet target promoters (insulin, IAPP, pax-4, glucokinase) and at the mafA enhancer, providing the first direct binding evidence in beta cells.\",\n      \"evidence\": \"ChIP in beta cells, EMSA, reporter assays, Nkx2.2-null analysis\",\n      \"pmids\": [\"12426319\", \"16847327\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors at these sites not yet defined\", \"Activator vs repressor mode site-specific\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established NKX2-2 as an obligatory downstream target of EWS/FLI required for Ewing's sarcoma tumorigenesis, extending its role beyond development to oncogenesis.\",\n      \"evidence\": \"RNAi knockdown, rescue, microarray profiling\",\n      \"pmids\": [\"16697960\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of transformation (repressor vs activator) not yet resolved\", \"Direct oncogenic targets unidentified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined NKX2-2 repressor activity as sufficient to rescue alpha and partial beta-cell fate, and showed it is required to maintain mature beta-cell function, linking transcriptional repression to islet identity and physiology.\",\n      \"evidence\": \"Transgenic Engrailed-repressor and dominant-derivative mice, glucose tolerance/insulin secretion assays, co-IP of Grg3\",\n      \"pmids\": [\"17202186\", \"17456846\", \"18022152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Activator functions needed for full beta-cell maturation not identified\", \"Distinction between developmental and maintenance targets incomplete\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolved the mechanism of NKX2-2-driven transformation in Ewing's sarcoma as repression-only, mapping DNA-binding and repressor domains as essential and implicating TLE/HDAC corepressors.\",\n      \"evidence\": \"Structure-function mutagenesis, ChIP-chip, pharmacological TLE/HDAC inhibition, RNAi\",\n      \"pmids\": [\"18414662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific repressed differentiation targets not fully enumerated here\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed NKX2-2 dual activity in islet cells: direct cooperative activation of NeuroD1 with Ngn3 and direct binding/regulation of the ghrelin promoter.\",\n      \"evidence\": \"ChIP, EMSA, reporter assays, KO mouse and zebrafish knockdown\",\n      \"pmids\": [\"19759004\", \"19965928\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Switch between activation and repression modes mechanistically unexplained\", \"Cofactor determinants of mode not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Assembled the NKX2-2 corepressor complex (DNMT3a, Grg3, HDAC1) and showed TN-domain recruitment of Grg3 directs Arx-promoter repression to prevent beta-to-alpha transdifferentiation, mechanistically linking corepressor recruitment to cell-identity maintenance.\",\n      \"evidence\": \"Co-IP, ChIP, TN-domain knock-in mice, DNMT3a beta-cell KO, Arx conditional rescue\",\n      \"pmids\": [\"22056672\", \"21856296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DNA methylation status is established at targets unresolved\", \"Full complex stoichiometry not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended the HDAC1-dependent repression mechanism to oligodendroglia, showing NKX2-2 represses Sirt2 via HDAC1 to time differentiation.\",\n      \"evidence\": \"ChIP, HDAC1 RNAi, overexpression in CG4 cells\",\n      \"pmids\": [\"21669943\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab cell-line evidence\", \"In vivo relevance of Sirt2 regulation untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified Pdgfra as a direct NKX2-2 repression target acting as a timing switch for oligodendrocyte differentiation.\",\n      \"evidence\": \"ChIP, conditional KO and OE in OPCs, genetic epistasis with Pdgfra KO\",\n      \"pmids\": [\"24449836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Corepressors at Pdgfra promoter not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed NKX2-2 represses cell adhesion and ECM genes (including zyxin) in Ewing's sarcoma, linking its repressor activity to control of migration and adhesion.\",\n      \"evidence\": \"RNA-seq after knockdown, adhesion/migration assays, immunofluorescence\",\n      \"pmids\": [\"26000096\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding to adhesion gene loci not all confirmed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified the importins (alpha1, beta1, importin 13) mediating NKX2-2 nuclear import and the differential NLS dependence among pathways.\",\n      \"evidence\": \"GST pulldown, in vitro import assays, importin RNAi, NLS mutagenesis\",\n      \"pmids\": [\"27956177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo redundancy of import pathways untested\", \"Single lab in vitro\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined NKX2-2 control of intestinal enteroendocrine fate at multiple stages, placing Lmx1a downstream in the enterochromaffin/serotonin program.\",\n      \"evidence\": \"Stage-specific conditional KO, lineage tracing, Lmx1a KO\",\n      \"pmids\": [\"27287799\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct intestinal target genes not mapped\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated NKX2-2 has essential, stage-specific functions within the Neurog3+ endocrine progenitor population, distinct from earlier pancreatic progenitor roles.\",\n      \"evidence\": \"Neurog3-Cre conditional KO vs germline null, expression analysis\",\n      \"pmids\": [\"28071588\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stage-specific direct targets not delineated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mapped domain-specific corepressor recruitment in oligodendrocytes: TN domain to GRG3, C-terminus to HDAC1/DNMT3A, with synergy and intramolecular suppression by the NK2 domain.\",\n      \"evidence\": \"Co-IP, in ovo electroporation, domain deletion analysis\",\n      \"pmids\": [\"31932307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct OL targets of each domain not enumerated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified NKX2-2 as the commitment factor for the type III taste cell lineage in posterior taste papillae, broadening its lineage-specification roles.\",\n      \"evidence\": \"Lineage tracing, KO analysis, single-cell RNA-seq, in situ hybridization\",\n      \"pmids\": [\"34097879\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct taste-lineage target genes unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established tissue-specific domain requirement: the NK2-specific domain is essential for beta-cell maturation (its mutation causes neonatal diabetes) but dispensable for CNS roles, and acts via chromatin remodeler and nuclear pore interactions.\",\n      \"evidence\": \"Endogenous SD point-mutant knock-in mice, expression analysis, co-IP; and disease-mutation functional assays\",\n      \"pmids\": [\"37364986\", \"37821536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of SD-dependent chromatin remodelers not fully defined in the SD study\", \"Disease mutation evidence from a single case\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined NKX2-2 cofactor logic for alpha-cell identity (KLF4 directs its promoter occupancy and chromatin accessibility) and beta-cell repression (CHD4 cooperates to silence non-beta genes), revealing how cofactors steer target selection.\",\n      \"evidence\": \"ChIP-seq, ATAC-seq, conditional KO and OE; proteomics, co-IP, conditional KO, calcium imaging (CHD4 preprint)\",\n      \"pmids\": [\"39797760\", \"40667117\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CHD4 findings are from a preprint not yet peer-reviewed\", \"How cofactor availability is set per cell type unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NKX2-2 switches between repressor and activator modes at individual loci, and how cofactor/chromatin context selects tissue-specific target sets, remains incompletely defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unifying biochemical model for activator-vs-repressor switching\", \"Structural basis of domain-specific cofactor selection unresolved\", \"Genome-wide direct targets across all lineages not comprehensively integrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 6, 13, 18, 30, 38]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [12, 13, 38]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": []}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [21, 22]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [7, 13, 30]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [6, 13, 18, 30]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 4, 23, 28, 36]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 6, 33, 38]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7, 25, 30]}\n    ],\n    \"complexes\": [\n      \"NKX2-2-Grg3-HDAC1-DNMT3A corepressor complex\",\n      \"HDAC1-mSin3A corepressor complex\"\n    ],\n    \"partners\": [\n      \"TLE/Grg3\",\n      \"HDAC1\",\n      \"DNMT3A\",\n      \"OLIG2\",\n      \"CHD4\",\n      \"KLF4\",\n      \"importin beta1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}